[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-370108-105":59,"doc-detail-370108-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","oncogenic-kraserkjunb-signaling-suppresses-differentiation-regulator-gata6-in-pancreatic-cancer","Oncogenic KRAS/ERK/JUNB signaling suppresses differentiation regulator GATA6 in pancreatic cancer","","Oncogenic KRAS-activated ERK signaling suppresses the pancreatic differentiation regulator GATA6 at the transcriptional level. GATA6 mRNA shows an inverse relationship with KRAS/ERK activity across pancreatic tumors. A genome-wide CRISPR screen identifies JUNB as an ERK-regulated transcriptional repressor of GATA6; ERK stabilizes JUNB, whereas KRAS/ERK inhibition triggers ubiquitin-independent proteasomal JUNB degradation and increases GATA6 transcription. Elevated GATA6 enhances chemosensitivity, and KRAS/ERK inhibitors synergize with chemotherapy in a GATA6-dependent manner.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/oncogenic-kraserkjunb-signaling-suppresses-differentiation-regulator-gata6-in-pancreatic-cancer/370108/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/oncogenic-kraserkjunb-signaling-suppresses-differentiation-regulator-gata6-in-pancreatic-cancer/370108.png","ImageObject",300,407,{"name":92,"@type":93},"CatatanPagi","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-05","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":34},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What role does GATA6 play in pancreatic cancer?","Question",{"text":112,"@type":113},"GATA6 is a master regulator of pancreatic differentiation. Its expression levels distinguish two main molecular subtypes and influence tumor differentiation and prognosis.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How does KRAS/ERK signaling affect GATA6 expression?",{"text":117,"@type":113},"Oncogenic KRAS-activated ERK signaling suppresses GATA6 transcription. GATA6 mRNA levels inversely correlate with KRAS/ERK activity in pancreatic tumors.",{"name":119,"@type":110,"acceptedAnswer":120},"Why is JUNB important for regulating GATA6?",{"text":121,"@type":113},"A genome-wide CRISPR screen identifies JUNB as the ERK-regulated transcriptional repressor for GATA6. Active ERK stabilizes JUNB, while KRAS/ERK inhibition promotes JUNB degradation and increases GATA6 transcription.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},370108,1790270050,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":34,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},962090894170,"https://ap-avatar.wpscdn.com/davatar_6f874abed73319feea01a86fa6f0fab8","The Journal of Clinical Investigation RESEAR CH ARTICLE  \nOncogenic KRAS/ERK/JUNB signaling suppresses differentiation regulator GATA6 in pancreatic cancer  \nZheng Zhong,1 Xinang Cao,2 Pei-Ju Liao,1 Raman Sethi,3 Jeffrey A. Klomp,4,5 Clint A. Stalnecker,4,5 Jinmiao Chen,1,3,6 Yue Wan,2 Channing J. Der,4,5 and David M. Virshup1,7  \n1Program in Cancer and Stem Cell Biology, Duke-NUS Medical School, Singapore. 2Genome Institute of Singapore and 3Bioinformatics Institute, Agency for Science, Technology and Research (A*STAR), Singapore. 4Lineberger Comprehensive Cancer Center and 5Department of Pharmacology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA. 6Centre for Computational Biology, Duke-NUS Medical School, Singapore. 7Department of Pediatrics, Duke University, Durham, North Carolina, USA.  \nGATA6 is a master regulator of differentiation in the pancreas, and its expression levels determine the 2 main molecular subtypes of pancreatic cancer. High GATA6 levels contribute to the classical pancreatic cancer subtype, which is associated with a higher degree of tumor differentiation and better disease prognosis. However, why GATA6 expression varies across pancreatic cancers and what regulates GATA6 expression remain elusive. Here, we report that oncogenic KRAS-activated ERK signaling suppresses GATA6 transcription in pancreatic cancers. GATA6 mRNA levels inversely correlated with KRAS/ERK activity in pancreatic tumors. A genome-wide CRISPR screen in a GATA6-EGFP reporter knockin cell line identified JUNB asthe ERK-regulated transcriptional repressor for GATA6. Active ERK stabilized JUNB protein, while KRAS/ERK inhibition led to ubiquitin-independent proteasomal degradation of JUNB and increased transcription of GATA6 . Upregulation of GATA6 enhanced chemosensitivity of pancreatic cancer cells, and KRAS/ERK inhibitors synergized with chemotherapy in a GATA6-dependent manner. Our study identifies how oncogenic KRAS/ERK signaling suppresses GATA6 to cause dedifferentiation in pancreatic cancer. Combining KRAS/ERK inhibitors with standard-of-care chemotherapies could be a promising therapeutic strategy for treating pancreatic cancers.  \nIntroduction  \nPancreatic cancer (pancreatic ductal adenocarcinoma [PDAC]) isone of the most lethal cancer types worldwide (1, 2) . Most pancreatic cancers are diagnosed at advanced stages, and the treatment for these patients largely relies on conventional chemoradiotherapies that provide only modest survival benefits (3) .  \nTranscriptomic analyses of pancreatic tumors have revealed 2 major molecular subtypes that are associated with distinct disease prognosis: the classical and basal-like subtypes (4, 5) . The classical subtype pancreatic cancers feature better tumor differentiation, less metastases, superior therapy response, and longer patient survival (5, 6) . Notably, the expression level of the GATA6 gene is sufficient to efficiently distinguish these 2 subtypes: high expression of GATA6 correlates well with the classical subtype, making GATA6 a valuable marker that could be incorporated into routine histological examinations for pancreatic cancers (5, 7) .  \nConflict of interest: CJD is a consultant/advisory board member for AskY Therapeutics, Cullgen, Deciphera Pharmaceuticals, Kestrel Therapeutics, Reactive Biosciences, Revolution Medicines, SHY Therapeutics, and Mirati Therapeutics Inc. , a Bristol Myers Squibb company. CJD has received research funding support from Deciphera Pharmaceuticals, Reactive Biosciences, Revolution Medicines, SpringWorks Therapeutics, and Mirati Therapeutics Inc. , a Bristol Myers Squibb company.  \nCopyright: © 2025, Zhong et al. This is an open access article published under the terms of the Creative Commons Attribution 4.0 International License.  \nSubmitted: January 28, 2025; Accepted: November 25, 2025;  \nPublished: December 2, 2025.  \nReference information: J Clin Invest. 2026;136(3):e191370 .  \n[https://doi.org/10.1172/JCI191370","cbCaij47IcjOdto1","https://ap.wps.com/l/cbCaij47IcjOdto1","pdf",9913385,17,"English","# Abstract\n## Molecular mechanism linking KRAS/ERK to GATA6\n## JUNB as an ERK-regulated repressor\n## Therapeutic implications for chemosensitivity","[{\"question\":\"What role does GATA6 play in pancreatic cancer?\",\"answer\":\"GATA6 is a master regulator of pancreatic differentiation. Its expression levels distinguish two main molecular subtypes and influence tumor differentiation and prognosis.\"},{\"question\":\"How does KRAS/ERK signaling affect GATA6 expression?\",\"answer\":\"Oncogenic KRAS-activated ERK signaling suppresses GATA6 transcription. GATA6 mRNA levels inversely correlate with KRAS/ERK activity in pancreatic tumors.\"},{\"question\":\"Why is JUNB important for regulating GATA6?\",\"answer\":\"A genome-wide CRISPR screen identifies JUNB as the ERK-regulated transcriptional repressor for GATA6. Active ERK stabilizes JUNB, while KRAS/ERK inhibition promotes JUNB degradation and increases GATA6 transcription.\"}]","Oncogenic KRAS/ERK/JUNB signaling suppresses differentiation regulator GATA6 in pancreatic cancer | PDF",1790186756,43,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/74738745e425e3b16da3f41de723d1ae.webp",983,1315,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/471af43a3be4970e843c33348e884c24.webp",982,1314,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/27ffd0e3673a04bfcfca54109844afa5.webp",981,1312,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c6f14b51eb921bf37d9072b5f0e5378c.webp",980,1311]